Poster

Therapeutic Areas

BioPharma R&D

M&S Expertise

See all Case Studies

Optimal therapeutic combinations for Phase 3 UC trial design- recommendations from a QSP platform model

Read More

Model-informed dose priming strategy for T cell engagers: Leveraging early clinical data to mitigate CRS

Read More

Bridging Preclinical Data and Human Dose Selection for ADCs: Lessons from Approved Molecules

Read More

Quantitative Systems Pharmacology (QSP) Modeling of efficacy and nausea of GLP-1 mono and dual (GLP-1/GIP) receptor agonists (RA) to support weight management and glycemic control in obese patients

Read More

Evaluating antibody drug conjugate (ADC) combinations using the platform Quantitative Systems Pharmacology (QSP) model

Read More

A Unified Mechanistic Framework for Modeling Short- and Long-Acting siRNAs: Impact of RISC Stability on PD Durability

Read More

Model-Informed Strategies for GLP-1 RA Development: Linking PKPD to Weight Loss and Glycemic Control

Read More

Predicting Phase3 efficacy of combination therapy in Ulcerative Colitis #IBD

Read More

From Xenograft to Clinic: QSP-guided dosing and step-up strategy for CD3×HLA-G T Cell Engagers TCE

Read More

Clinical Efficacy and cytokine release syndrome (CRS) risk of CD3 Bispecifics in prostate cancer

Read More

Stay connected with Vantage Research
Scroll to Top